Trial intelligence / Profile preview

Preoperative Antithrombin Supplementation in Cardiac Surgery

NCT00823082Phase 2Completed

Sponsor
Grifols
Start
Jun 2009
Primary completion
Jun 2011
Modality
rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 2 trial of Anbinex in acquired antithrombin III deficiency, sponsored by Grifols. Started Jun 2009; status: completed.

02

Drugs

Anbinex
03

Conditions

acquired antithrombin III deficiency

Beyond the preview

Go deeper on NCT00823082.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00823082.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call